Published in
American Association for the Advancement of Science, Science Immunology, 59(6), 2021
DOI: 10.1126/sciimmunol.abh2383
Links
Tools
Targeting monoamine oxidase A for T cell–based cancer immunotherapy
Journal article published in 2021 by
Xi Wang 
,
Bo Li ,
Yu Jeong Kim,
Yu-Chen Wang,
Zhe Li,
Jiaji Yu,
Samuel Zeng,
Xiaoya Ma,
In Young Choi,
Stefano Di Biase,
Drake J. Smith,
Yang Zhou,
Yan-Ruide Li,
Feiyang Ma ,
Jie Huang
and other authors.
,
Bo Li ,
Yu Jeong Kim,
Yu-Chen Wang,
Zhe Li,
Jiaji Yu,
Samuel Zeng,
Xiaoya Ma,
In Young Choi,
Stefano Di Biase,
Drake J. Smith,
Yang Zhou,
Yan-Ruide Li,
Feiyang Ma ,
Jie Huang
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Monoamine oxidase A (MAO-A) restrains antitumor T cell immunity, suggesting potential use of MAO-A inhibitors in cancer immunotherapy.